SEROPREVALENCE OF HIV, HBV, HCV, SYPHILIS AMONG DONORS OF BLOOD AT THE NATIONAL CENTER OF BLOOD TRANSFUSION ANTANANARIVO IN 2014

Simple item page
dc.creatorAndriamandimbisoa, Herinjaka
dc.creatorAndrianarivelo, Andry
dc.creatorRakotoarisoa, Arinomenjanahary
dc.creatorRasamiravaka, Tsiry
dc.creatorRandriamboavonjy, Rado
dc.creatorFortune, H.
dc.creatorOlivat Rakoto, Alison
dc.creatorRasamindrakotroka, Andry
dc.date.accessioned2026-01-10T18:52:45Z
dc.date.available2026-01-10T18:52:45Z
dc.date.issued2017-01-14
dc.descriptionIntroduction: Currently, routine screening for HIV, hepatitis B and C and syphilis is done in most blood banks in the world. Methods: We conducted a prospective descriptive study at the National Blood Transfusion Center (CNTS) Antananarivo for a period of 7 months from January to July 2014, which aims to assess the socio-clinical factors accompanying ineligibility of blood products and to determine the seroprevalence of HIV, hepatitis B, C and syphilis of the blood donors who have spent at CNTS HU JRA Antananarivo during this period. All donors who have abnormal results of microbiological examinations were included. The parameters used and studied were age, sex, marital status, blood and results microbiological examinations for HIV, hepatitis B, C, and syphilis. The prevalence of blood donors who presented a serological abnormality is 3.95% with a predominance of donors with hepatitis B (72.93%) followed by syphilis (18.29%) of the hepatitis C (6.95%) and HIV (1.80%) and a predominance of young people. Conclusion: At the CNTS Antananarivo, the HBV is the main definitive reason for exclusion of these donors. This high prevalence is a real public health problem for the country's health authorities. The search for maximum safety in blood transfusion through firstly a better selection of blood donors by implementing a policy of strong loyalty and other early diagnosis of major diseases transmissible by blood and likely to infect the recipient. KEYWORDS: Antananarivo; Blood donor; Microbiology; Seroprevalence.en-US
dc.formatapplication/pdf
dc.identifierhttps://sumathipublications.com/index.php/ijcbr/article/view/130
dc.identifier.urihttps://repos.sumathipublications.com:8000/handle/123456789/127
dc.languageeng
dc.publisherSumathi Publicationsen-US
dc.relationhttps://sumathipublications.com/index.php/ijcbr/article/view/130/156
dc.relation.ispartofInternational Journal of Clinical and Biomedical Researchen-US
dc.relation.ispartofseriesVolume 3, Issue 1en-US
dc.rightsCopyright (c) 2017 Herinjaka Andriamandimbisoa, Andry Andrianarivelo, Arinomenjanahary Rakotoarisoa, Tsiry Rasamiravaka, Rado Randriamboavonjy, H. Fortune, Alison Olivat Rakoto, Andry Rasamindrakotrokaen-US
dc.sourceInternational Journal of Clinical and Biomedical Research; Volume 3, Issue 1; January 2017; 8-12en-US
dc.source2395-0471
dc.source2521-0394
dc.titleSEROPREVALENCE OF HIV, HBV, HCV, SYPHILIS AMONG DONORS OF BLOOD AT THE NATIONAL CENTER OF BLOOD TRANSFUSION ANTANANARIVO IN 2014en-US
dc.typeinfo:eu-repo/semantics/article
dc.typeinfo:eu-repo/semantics/publishedVersion

Files

Collections

International Journal of Clinical and Biomedical Research (IJCBR)